We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$143M
AUM Growth
+$17.2M
Cap. Flow
+$2.03M
Cap. Flow %
1.42%
Top 10 Hldgs %
32.26%
Holding
996
New
133
Increased
222
Reduced
163
Closed
42

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$1.87M
2
GS icon
Goldman Sachs
GS
+$1.4M
3
IRBT
iRobot
IRBT
+$1.1M
4
AMAT icon
Applied Materials
AMAT
+$965K
5
EVR icon
Evercore
EVR
+$867K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.43M
2
CL icon
Colgate-Palmolive
CL
+$1.03M
3
CAH icon
Cardinal Health
CAH
+$1M
4
NXPI icon
NXP Semiconductors
NXPI
+$807K
5
ALGN icon
Align Technology
ALGN
+$791K

Sector Composition

Rank Sector Weight
1 Technology 22.63%
2 Healthcare 11.54%
3 Financials 11.13%
4 Industrials 6.13%
5 Consumer Staples 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDN icon
451
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
$9K 0.01%
78
FNDF icon
452
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$9K 0.01%
315
FXI icon
453
iShares China Large-Cap ETF
FXI
$4.31B
$9K 0.01%
180
IYR icon
454
iShares US Real Estate ETF
IYR
$4.59B
$9K 0.01%
120
NTES icon
455
NetEase
NTES
$76.5B
$9K 0.01%
155
-5
-3% -$314
PGHY icon
456
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$221M
$9K 0.01%
400
PSK icon
457
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$9K 0.01%
215
REGN icon
458
Regeneron Pharmaceuticals
REGN
$68.8B
$9K 0.01%
+27
New +$9.39K
TEVA icon
459
Teva Pharmaceuticals
TEVA
$35.9B
$9K 0.01%
538
-6
-1% -$117
TTC icon
460
Toro Company
TTC
$8.93B
$9K 0.01%
+143
New +$9.11K
WPM icon
461
Wheaton Precious Metals
WPM
$50.6B
$9K 0.01%
445
-8
-2% -$164
ABB
462
DELISTED
ABB Ltd
ABB
$9K 0.01%
365
+262
+254% +$6.74K
SHI
463
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$9K 0.01%
150
+104
+226% +$6.28K
NFX
464
DELISTED
Newfield Exploration
NFX
$9K 0.01%
388
-14
-3% -$393
ATI icon
465
ATI
ATI
$27B
$8K 0.01%
325
-7
-2% -$188
BSX icon
466
Boston Scientific
BSX
$65.8B
$8K 0.01%
300
CBOE icon
467
Cboe Global Markets
CBOE
$29.8B
$8K 0.01%
66
CSGP icon
468
CoStar Group
CSGP
$11.3B
$8K 0.01%
+230
New +$7.93K
CYD icon
469
China Yuchai International
CYD
$1.69B
$8K 0.01%
400
+251
+168% +$6.06K
DEM icon
470
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.88B
$8K 0.01%
175
HTHT icon
471
Huazhu Hotels Group
HTHT
$12.4B
$8K 0.01%
228
+164
+256% +$6K
IOO icon
472
iShares Global 100 ETF
IOO
$8.56B
$8K 0.01%
180
JCI icon
473
Johnson Controls International
JCI
$87.5B
$8K 0.01%
238
LEMB icon
474
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$749M
$8K 0.01%
150
MA icon
475
Mastercard
MA
$477B
$8K 0.01%
45
-455
-91% -$77.8K

Similar funds

Front Row Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Front Row Advisors held 996 positions worth $143M, up 14% from $126M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Front Row Advisors's Q1 2018 filing shows 133 new, 222 increased, 163 reduced and 42 closed positions. Its largest new stake was iRobot: 14,580 shares worth $936K. The largest sale was 3M, an estimated $1.43M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q1 2018 buy was iRobot: 14,580 shares worth $936K.
  • Front Row Advisors added most to Emerson Electric in Q1 2018, an estimated $1.87M increase.
  • Front Row Advisors's biggest Q1 2018 reduction was 3M, cutting an estimated $1.43M.
  • Front Row Advisors fully exited Cardinal Health in Q1 2018, selling an estimated $1M.
  • Front Row Advisors's ten largest holdings make up 32% of its $143M portfolio in Q1 2018.
  • Front Row Advisors opened 133 new positions and closed 42 in Q1 2018.
  • Front Row Advisors's portfolio value rose 14% quarter-over-quarter to $143M.

Based on Front Row Advisors's 13F filing for Q1 2018, filed 21 May 2018.